A common osteoporosis drug blocked spinal damage in a surprising new study

1 day ago

An existing osteoporosis drug has shown surprising promise in protecting the spine from damage, raising hopes for new treatments for chronic neck and back pain. In experiments involving zebrafish, researchers found that the medication prevented abnormal mineral deposits from forming in the spine, a process that can cause spinal tissues to harden and vertebrae to fuse together.

The discovery could help scientists tackle one of the underlying causes of back pain...

Read Entire Article